Multicentric - OmicsDI

Show results for

Unknown (2059)
Genomics (119)
Transcriptomics (59)
Clinical (45)
Proteomics (11)
Metabolomics (7)
Genomic (4)
Methylation profiling (4)
Other (1)

Organisms

Homo sapiens (87)
Aggregatibacter actinomycetemcomitans (4)
Archaea (4)
Bacteria (4)
Borrelia (4)
Botrytis cinerea (4)
Candida albicans (4)
Clostridium perfringens (4)
Cnidaria (4)
Eukaryota (4)
Fasciola (4)
Fungi (4)
Hepatitis B virus (4)
Human betaherpesvirus 5 (4)
Influenza C virus (4)
Japanese encephalitis virus group (4)
Miscanthus x giganteus (4)
Mycobacterium tuberculosis (4)
Orthoflavivirus (4)
Panicum virgatum (4)
Rattus norvegicus (3)
Schizosaccharomyces pombe (2)
Drosophila melanogaster (2)
Zea mays (1)
Plasmodium falciparum 3D7 (1)
Oncorhynchus mykiss (1)
Sus scrofa (1)
Agrobacterium tumefaciens (1)
Human gammaherpesvirus 8 (1)
Mus musculus (1)

Organisms

Homo sapiens (54)
Canis lupus familiaris (2)
Agrobacterium tumefaciens (1)
Ralstonia mannitolilytica (1)
feces metagenome (1)
Escherichia coli (1)
human gut metagenome (1)
Mus musculus (1)

Repository

ENA (89)
geo (48)
biostudies-arrayexpress (28)
EGA (24)
MetaboLights (7)
dbGaP (4)
pride (4)
MassIVE (1)

Tissue

Blood plasma (1)
Blood platelet (1)
Blood serum (1)
Permanent cell line cell (1)
Urine (1)

Disease

Colorectal Neoplasms (16)
Neoplasms (6)
Neoplasm Metastasis (4)
Bladder tumour (1)
Metastatic hepatocellular carcinoma (1)
Krukenberg Tumor (1)
Major Surgery (1)
Patients with metastatic colon-rectal cancer (1)
Ascites (1)
Colorectal cancer (1)
Biliary Tract Neoplasms (1)
Benign neoplasm esophagus, stomach, duodenum, colon or rectum.Malignant neoplasm esophagus, stomach, duodenum, colon and rectum (1)
Lymph Node Cancer Metastatic (1)
Leukemia, Lymphoid (1)
Malignant neoplasm of colon, unspecified (1)
Hematologic Neoplasms (1)
Carcinoma, Non-Small-Cell Lung (1)
Gastrointestinal Stromal Tumors (1)
Stomach Neoplasms (1)
Colorectal Cancer (1)
Colorectal cancer (1)
Rectal Neoplasms (1)
Metastatic colorectal cancer (1)
Adenoma (1)
COVID-19 (1)
Sarcoma (1)

Technology Type

Mass spectrometry (6)
Mass Spectrometry (4)
Illumina Genome Analyzer II, Illumina HiSeq 2000 (2)
Illumina HiSeq 2000, ILLUMINA (2)
Bottom-up proteomics (2)
Shotgun proteomics (2)
Illumina Genome Analyzer IIx, Illumina HiSeq 2000 (1)
Mass spectrometry assay (1)
Data-dependent acquisition (1)

Instrument Platform

Q Exactive (4)
Illumina Genome Analyzer IIx;Illumina HiSeq 2000 (1)
Orbitrap Exploris 480 (1)
Q Exactive HF-X (1)
Direct infusion MS - negative (1)
Liquid Chromatography MS - Positive (LC-MS (Positive)) (1)
Direct infusion MS - positive (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)

Publication Date

2025 (12)
2019 (10)
2015 (8)
2024 (8)
2016 (6)
2010 (5)
2021 (5)
2013 (4)
2012 (4)
2008 (4)
2014 (3)
2026 (3)
2022 (3)
2020 (3)
2011 (2)
2006 (2)
2023 (2)
2018 (1)
2009 (1)
2017 (1)
2007 (1)

CHEBI ID

CHEBI:2676 (4)
CHEBI:133185 (4)
CHEBI:133066 (4)
CHEBI:16811 (4)
CHEBI:68433 (4)
CHEBI:46195 (4)
CHEBI:16919 (4)
CHEBI:27897 (4)
CHEBI:28177 (4)
CHEBI:70976 (4)
CHEBI:133109 (3)
CHEBI:133225 (3)
CHEBI:133588 (3)
CHEBI:133680 (3)
CHEBI:133686 (3)
CHEBI:133073 (3)
CHEBI:133571 (3)
CHEBI:133729 (3)
CHEBI:133546 (3)
CHEBI:133560 (3)
CHEBI:133205 (3)
CHEBI:133550 (3)
CHEBI:133502 (3)
CHEBI:133563 (3)
CHEBI:72837 (3)
CHEBI:76942 (3)
CHEBI:52031 (3)
CHEBI:133684 (3)
CHEBI:3561 (3)
CHEBI:83501 (3)

Metabolite Name

N-acetyltryptophan (4)
Glycochenodeoxycholate glucuronide (3)
5alpha-androstan-3alpha,17beta-diol monosulfate (3)
1,2,3-benzenetriol sulfate (3)
Glycodeoxycholate sulfate (3)
Glycochenodeoxycholate sulfate (3)
5-bromotryptophan (3)
Homostachydrine (3)
Glycolithocholate sulfate (3)
Gamma-CEHC glucuronide (3)
3-(cystein-S-yl)acetaminophen (3)
2-methoxyacetaminophen sulfate (3)
2-methoxyacetaminophen glucuronide (3)
2-hydroxyacetaminophen sulfate (3)
1-palmitoyl-2-oleoyl-GPI (16:0/18:1) (3)
1-linoleoyl-GPI (18:2) (3)
3-hydroxybutyrylcarnitine (3)
9-hydroxystearate (3)
1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) (3)
Sulfamethoxazole (3)
Amoxicillin (3)
Pregabalin (3)
Acesulfame (3)
2-methoxyresorcinol sulfate (3)
3-methoxytyramine sulfate (3)
Alliin (3)
Pantoprazole (3)
L-urobilin (3)
Ibuprofen acyl glucuronide (3)
Hyocholate (3)

First Public Date

2024 (15)
2025 (14)
2019 (11)
2026 (8)
2023 (8)
2022 (6)
2020 (6)
2014 (5)
2018 (4)
2017 (4)
2015 (4)
2021 (2)
2016 (2)

Classification

bacteria (1)

Study status

Completed (19)
Not provided (8)
Active, not recruiting (6)
Recruiting (4)
Not yet recruiting (4)
Terminated (3)
Ongoing (1)

Study type

Interventional (33)
Transcription profiling by array (20)
Observational (9)
RNA-seq of coding RNA (4)
Comparative genomic hybridization by array (3)
Observational patient registry (3)
Genotyping by array (1)

Release Date

2025 (337)
2022 (334)
2023 (301)
2024 (268)
2021 (244)
2020 (153)
2019 (82)
2018 (73)
2017 (44)
2015 (39)
2026 (35)
2016 (33)
2014 (32)
2013 (20)
2012 (19)
2011 (18)
2010 (18)
2008 (10)
2001 (6)
2007 (5)
2009 (4)
2006 (4)
1999 (3)
2005 (2)
2004 (1)
2003 (1)
2002 (1)

Lab affiliation

Biological Sciences, Towson University, Towson, Maryland, United States (1)
Clinical Proteomics (1)
ProteoRed-ISCIII, Proteomics Platform, Barcelona Science Park, Barcelona, Spain. (1)
Thermo Fisher Scientific (1)

Location

France (17)
Spain (9)
Italy (8)
Germany (4)
Japan (3)
India (2)
Poland (2)
Argentina (2)
Australia (2)
Belgium (2)
Lithuania (1)
Latvia (1)
Singapore (1)
Denmark (1)
Israel (1)
United Kingdom (1)
Russia (1)
South Korea (1)
Austria (1)
China (1)
Switzerland (1)
United States (1)

Keyword

Cetuximab (5)
Oxaliplatin (4)
HIPEC (3)
Erbitux (3)
Irinotecan (3)
Leucovorin (3)
Controlled clinical trial (2)
Gemcitabine (2)
Cisplatin (2)
Metastasis (2)
Avelumab (2)
Fluorouracil (2)
Células dendríticas maduras (1)
Resectable hepatic metastasis (1)
Cetuximab rechallenge (1)
Two stage surgery for the resection of hepatic metastases (1)
Resorbable barrier membrane (1)
Abdominal and peri-hepatic adhesion (1)
Hyaluronic Acid (1)
BIBW2992 (1)
Glivec (1)
Pressurized IntraPeritoneal Aerosol Chemotherapy (1)
Pressurized IntraThoracic Aerosol Chemotherapy (1)
PITAC (1)
Doxorubicine (1)
Phase III (1)
Genetic profiling (1)
CAMPTO 1 FL 100 MG/5ML (1)
CAMPTO 1 FL 40 MG/2ML (1)
ELOXATIN IV 1 FL 100 MG (1)

Previous page
1 / 231
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 231
Next page

Sort by:

Relevance

Page size

An interoperability framework for multicentric breath metabolomic studies

Exhaled breath contains valuable information at the molecular level and offers promising potential for precision medicine. However, few breath tests transition to routine clinical practice, partly because of the missing validation in multicenter trials. Therefore, we developed and applied an interop...

2022-10-27 | MTBLS5657 | MetaboLights

Multicentric Castleman Disease

PRJNA1006393 | ENA

CCG Multicentric Italian Lung Detection

PRJNA671447 | ENA

CCG Multicentric Italian Lung Detection

PRJNA671446 | ENA

The lymph node transcriptome of unicentric and idiopathic multicentric Castleman disease

PRJNA800773 | ENA

scRNAseq of PBMCs from idiopathic multicentric Castleman Disease (iMCD) flare and remission

We performed scRNAseq of PBMCs from three idiopathic multicentric Castleman Disease (iMCD) patients with paired flare and remission samples

ORGANISM(S): Homo sapiens

2020-05-20 | GSE140881 | GEO

scRNAseq of PBMCs from idiopathic multicentric Castleman Disease (iMCD) flare and remission

PRJNA591202 | ENA

Common Connective Tissue Disorder and Anti-Cytokine Autoantibodies are Enriched in Idiopathic Multicentric Castleman Disease Patients

We measued IgG autoantibodies associated with Connective Tissue Diseases (CTDs) and Anti-Cytokine Antibodies (ACA) in idiopathic Multicentric Castleman Disease (iMCD) patients and healthy controls who received the BNT162b2 vaccine.

ORGANISM(S): Homo sapiens

2025-02-26 | GSE290521 | GEO

ProteoRed Multicentric Experiment for Proteomics Quality Control

Proteomic technologies based on mass spectrometry (MS) have greatly evolved in the past years, and nowadays it is possible to routinely identify thousands of peptides from complex biological samples in a single LC-MS/MS experiment. Despite the advancements in proteomic technologies, the scientific c...

ORGANISM(S): Saccharomyces cerevisiae BY4741

2015-07-20 | PXD000205 | Pride

Reproducibility Qc Orbitrap Multicentric

CXCL13 is a predictive biomarker in idiopathic multicentric Castleman disease

PRJNA898421 | ENA

Previous page
1 / 231
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 231
Next page

Sort by:

Relevance

Page size

2309 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Classification

Study status

Study type

Release Date

Lab affiliation

Location

Tags

Keyword

OmicsDI is part of the ELIXIR infrastructure

Tweets